Association between protein dose in the early and late acute phases of critical illness and time‐to‐discharge‐alive: A secondary analysis of a randomized clinical trial
Open Access
- 14 November 2025
- journal article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 50 (2) , 183-191
Abstract
Background: Research has sought to identify optimal protein doses during acute phases of critical illness to optimize outcomes. Methods: A secondary analysis of the EFFORT Protein trial, which compared high vs usual protein ( N = 1301). Only participants with 8 evaluable days of protein intake were included in our analysis. Mean protein intake was categorized as low (1.3 g/kg/day). Acute illness phases were define as early (days 1–4) and late (days 5–8). Participants were grouped by protein dose received in each phase. Based on prior evidence, early phase medium protein/late phase high protein served as the referent. The primary outcome was time‐to‐discharge‐alive; secondary outcomes included 60‐day mortality and discharge home. Results: We identified 819 participants (median [IQR] age 59.0 [46.0, 69.0] years; 60% male). Time‐to‐discharge‐alive did not differ significantly across groups ( P = 0.19). The early low/late high‐protein and early high/late high‐protein groups had hazard ratios of 0.63 (95% CI, 0.35–1.11) and 0.70 (95% CI, 0.46–1.06), respectively. Mortality and discharge‐home rates did not differ significantly across protein dose/acute phase groups ( P = 0.85 and 0.65, respectively). Conclusion: We hypothesized that early medium and late high protein would improve outcomes; however, no significant differences between were observed across protein dose/acute phase groups. These findings are hypothesis‐generating and highlight the need for future research to identify biomarkers or scoring tools that better define phase transitions in critical illness, enabling more precise nutrition strategies. Trial Registration (Primary): NCT03160547Keywords
This publication has 28 references indexed in Scilit:
- Association of Baseline Inflammation With Effectiveness of Nutritional Support Among Patients With Disease-Related MalnutritionJAMA Network Open, 2020
- Timing of PROTein INtake and clinical outcomes of adult critically ill patients on prolonged mechanical VENTilation: The PROTINVENT retrospective studyClinical Nutrition, 2019
- ESPEN guideline on clinical nutrition in the intensive care unitClinical Nutrition, 2019
- Pathophysiology of Critical Illness and Role of NutritionNutrition in Clinical Practice, 2018
- The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Registry‐Based Randomized Trial: The EFFORT TrialJournal of Parenteral and Enteral Nutrition, 2018
- Early goal-directed nutrition versus standard of care in adult intensive care patients: the single-centre, randomised, outcome assessor-blinded EAT-ICU trialIntensive Care Medicine, 2017
- Identifying critically-ill patients who will benefit most from nutritional therapy: Further validation of the “modified NUTRIC” nutritional risk assessment toolClinical Nutrition, 2016
- SARC-F: A Simple Questionnaire to Rapidly Diagnose SarcopeniaJournal of the American Medical Directors Association, 2013
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Multiple Imputation for Nonresponse in Surveys1987